Skip to main content

NeuroReady®: Advanced Practice Provider (Second Edition)

NeuroReady®: Advanced Practice Provider (Second Edition)

Course Description

The NeuroReady: Advanced Practice Provider (Second Edition) is designed to provide foundational knowledge for APPs who are one to three years out of graduation, or who are new to the field neurology.

CORE Competencies

Medical Knowledge

CONTENT INCLUDED

Headache and Pain Disorders
Epilepsy and Episodic Disorders
Sleep Disorders
Cognitive and Behavioral Disorders
Cerebrovascular Disorders
Neuromuscular Disorders
Movement Disorders
Demyelinating and Immunologic Disorders
Neuroanatomy
Infectious Disease
*The clinical neurology content of this course was adapted from the AAN's NeuroReady: Board Prep Edition.

Learning Objectives

As a result of this course, the learner will be able to:
  • Identify areas of neurology that require more focused study and review.
  • Self-assess knowledge after completion of the educational program to further focus study and review.
  • Demonstrate improved competency and performance in clinical neurology.

Date of Release

July 15, 2022. This program is eligible for CME credits until July 15, 2025.

System Requirements

A web browser including Microsoft Internet Explorer 8 or greater or Chrome, Safari, or Firefox is required.

ACCREDITATION
The The American Academy of Neurology Institute (AANI), a subsidiary of the American Academy of Neurology (AAN), is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

AMA CREDIT DESIGNATION STATEMENT
The American Academy of Neurology Institute (AANI) designates this enduring materials for a maximum of 12 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Confidentiality of Data

All material © American Academy of Neurology Institute unless otherwise indicated. All rights reserved. See complete Terms of Use.

Faculty & Disclosures

The thoughts and opinions expressed in this course do not represent those of any of the institutions mentioned in this course, but are those of the individual clinicians featured.

Felicia Gliksman, DO, Chair

Pediatric Neurology Specialist
Hackensack University Medical Center
Hackensack, NJ
*Dr. Gliksman has nothing to disclose.

Aliza Ben-Zacharia, PhD, DNP, ANP-BC, FAAN

Assistant Professor
Hunter Bellevue School of Nursing
New York, NY
*Dr. Ben-Zacharia has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Ben-Zacharia has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Ben-Zacharia has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Celgene. Dr. Ben-Zacharia has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Greenwich. The institution of Dr. Ben-Zacharia has received research support from Biogen.

Rohit Das, MD, FAAN
Associate Professor, Neurology
UT Southwestern Medical center
Dallas, TX
*Dr. Das has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for janicek. The institution of an immediate family member of Dr. Das has received research support from NIH.

Ligia Viorela Onofrei, MD

Assistant Professor
University of Utah
Salt Lake City, UT
*Dr. Onofrei has nothing to disclose.

Khyati Patel, NP

Nurse Practitioner, Neurology
University of North Carolina
Chapel Hill, NC
*Ms. Patel has nothing to disclose.

Vanessa L. Carey MSN, ARNP
Nurse Practitioner
University of Washington
Seattle, WA
*Ms. Carey has nothing to disclose.

Shilpa Chitnis, MD, PhD, FAAN, FANA

Professor of Neurology
UT Southwestern Medical Center
Dallas, TX
*Dr. Chitnis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbott neuromodulation. Dr. Chitnis has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Skypass Foundation. Dr. Chitnis has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Skypass Foundation. Dr. Chitnis has received publishing royalties from a publication relating to health care.

Flavia B. Consens, MD
Associate Professor
Sleep Disorders Center - University of Washington
Seattle, WA
*Dr. Consens has nothing to disclose.

Hao Huang, MD
Assistant Professor
Hackensack University Medical Center
Hackensack, NJ
*Dr. Huang has nothing to disclose.

Alka Khera, MD
Assistant Professor
University of Texas Southwestern
Dallas, TX
*Dr. Khera has nothing to disclose.

Jawad F. Kirmani, MD
Director, Stroke and Neurovascular Center
JFK University Medical Center
Edison, NJ
*Dr. Kirmani has nothing to disclose.

Steven Krieger, MD, FAAN

Professor of Neurology
Mount Sinai Department of Neurology
New York, NY
Dr. Krieger has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Krieger has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Krieger has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Krieger has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Krieger has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for TG Therapeutics. Dr. Krieger has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Krieger has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Expert Witness. The institution of Dr. Krieger has received research support from Novartis. The institution of Dr. Krieger has received research support from Bristol Myers Squibb.

Suzette M. LaRoche, MD, FAAN
Medical Director
University of North Carolina
Chapel Hill, NC
*Dr. LaRoche has received publishing royalties from a publication relating to health care. Dr. LaRoche has a non-compensated relationship as a President with American Clinical Neurophysiology Society that is relevant to AAN interests or activities.

Rebecca Logan, PA
Physician Assistant
UT Southwestern Medical Center
Dallas, TX
*Ms. Logan has nothing to disclose.

Erika Masias, NP
Nurse Practitioner
Hackensack University Medical Center - Neuroscience Institute
Hackensack, NJ
*Mrs. Masias has nothing to disclose.

Joan Miravite, FNP

Assistant Professor of Neurology
Mount Sinai
New York, NY
*Ms. Miravite has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medtronic. Ms. Miravite has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbott. Ms. Miravite has received personal compensation in the range of $5,000-$9,999 for serving as a Faculty with Mount Sinai Beth Israel.

Sarah Parker, NP
Nurse Practitioner
Duke Health
Durham, NC
*Mrs. Parker has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amylyx.

Brigitte Percival
Nurse Practitioner
JFK Neuroscience Institute
Edison, NJ
*Ms. Percival has nothing to disclose.

Abigail Taylor, PA
Neurohospitalist - Physician Assistant
Mayo Clinic Hospital
Phoenix, AZ
*Ms. Taylor has nothing to disclose.

AAN STAFF

Susan Rodmyre
Senior Director, Education & Research
Minneapolis, MN
*Ms. Rodmyre has nothing to disclose.

Xiayou Sun
Associate Director, eLearning
Minneapolis, MN
*Ms. Chamberlain has nothing to disclose.

Robert Rook
Senior Program Manager, eLearning
Minneapolis, MN
*Mr. Rook has nothing to disclose.

Michaela Morris
Program Manager, eLearning
Minneapolis, MN
*Ms. Morris has nothing to disclose.

Andrea Weiss
Executive Editor, Education and News Publications
Minneapolis, MN
*Ms. Weiss has nothing to disclose.

Debra Zoellner
Production Editor
Minneapolis, MN
*Ms. Zoellner has nothing to disclose.
*Relationship Disclosure
+ Unlabeled Use of Products/Investigational Use Disclosure